$0.03
$-0.01 (-25.00%)
End-of-day quote: 04/04/2023
NasdaqGM:VIVO
Meridian Bioscience Competitors
| Ticker | Name | Exchange | Consensus | Price | Price Target | Upside/Downside | Analysts | Market Cap |
|---|---|---|---|---|---|---|---|---|
| TMO | Thermo Fisher Scientific | NYSE | Outperform | $595.30 | $591.94 | 0.00% | 1 | $227.24B |
| ROG | Roche Holding | SWX | Hold | CHF237.10 | CHF307.83 | 0.00% | 9 | CHF191.28B |
| DHR | Danaher | NYSE | Outperform | $265.80 | $260.33 | 0.00% | 4 | $196.87B |
| ABT | Abbott Laboratories | NYSE | Outperform | $104.09 | $118.92 | 0.00% | 7 | $181.08B |
| SIE | Siemens | XTRA | Outperform | 172.56€ | 178.14€ | 0.00% | 11 | 135.26€B |
| BDX | Becton Dickinson and Co | NYSE | Outperform | $236.30 | $284.47 | 0.00% | 8 | $68.29B |
| ILMN | Illumina | NasdaqGS | Outperform | $111.07 | $159.28 | 0.00% | 9 | $17.69B |
| BIM | bioMérieux | ENXTPA | Outperform | 95.90€ | 105.55€ | 0.00% | 1 | 11.73€B |
| TECH | Bio-Techne Corp | NASDAQ | Buy | $83.81 | $100.78 | 0.00% | 2 | $12.55B |
| MYGN | Myriad Genetics | NasdaqGS | Outperform | $25.29 | $22.08 | 0.00% | 8 | $1.79B |
| OSUR | OraSure Technologies | NasdaqGS | Hold | $4.92 | $7.40 | 0.00% | 4 | $406.27M |
| BCART | Biocartis Group NV | ENXTBR | - | 0.29€ | 1.10€ | 0.00% | 0 | 27.24€M |
| TRIB | Trinity Biotech | NasdaqGS | - | $1.58 | $3.00 | 0.00% | 0 | $24.08M |
| AXDX | Accelerate Diagnostics | NasdaqCM | Buy | $0.88 | $5.00 | 0.00% | 1 | $19.07M |
| OPGN | OpGen | NasdaqCM | $0.46 | $3.00 | 0.00% | 1 | $5.81M |
